A new drug is showing promise in shielding against the harmful effects of traumatic brain injury (TBI) in rats, according to a study that was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting April 21 to April 28, 2012. "There are currently no primary treatments for TBI, so this research provides hope that effective treatments can be developed," said study author Michael Kaufman, a second year medical student at Wayne State University's School of Medicine and a member of the American Academy of Neurology. The principal investigator on the study is Dr. Christian Kreipke, also with Wayne State University School of Medicine.

http://www.news-medical.net/news/20120219/Clazosentan-drug-shows-promise-against-TBI-in-rats.aspx
http://mms.tveyes.com/Transcript.asp?StationID=5425&DateTime=2%2F20%2F2012+5%3A14%3A13+AM&LineNumber=&MediaStationID=5425&playclip=True&RefPage=
http://mms.tveyes.com/Transcript.asp?StationID=2145&DateTime=2%2F20%2F2012+6%3A26%3A08+AM&LineNumber=&MediaStationID=2145&playclip=True&RefPage